SkinSight™ AI by ModuleMD: Smarter Skin Analysis, Faster Clinical Decisions

GRAND BLANC, Mich., Dec. 10, 2025 /PRNewswire/ -- ModuleMD, ranked as one of America's fastest-growing companies on the Inc. 5000 and top-rated EHR vendor on G2, announces SkinSight™ AI, a solution that brings automation, accuracy, and consistency to one of the most manual and variable workflows in allergy care: skin test measurement and documentation.

For years, allergy practices have been expected to deliver better documentation, clearer outcomes, and stronger patient communication while reimbursement remains unchanged.

SkinSight™ AI introduces a new era of standardization that meets these growing operational demands without adding work, steps, or hardware.

Why SkinSight™ AI Matters Today

Allergy skin testing remains highly subjective, often relying on staff experience, manual measurement, and individual interpretation. SkinSight™ AI removes these inconsistencies and replaces them with an objective, data-driven process designed for accuracy, efficiency, and trust.

Sign up for Blog Updates